HIMS NYSE
Hims & Hers Health, Inc.
1W: -1.4%
1M: +1.1%
3M: -24.2%
YTD: -13.2%
1Y: -48.5%
3Y: +366.2%
5Y: +258.0%
$29.00
-0.30 (-1.02%)
Weekly Expected Move ±6.4%
$25
$27
$29
$31
$33
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
10 relationships10
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2025-05-13
Earliest Filing
2026-02-19
Latest Filing
investor: 5
acquirer: 2
partner: 2
target: 1
Counterparties (Filed by HIMS)
10 relationshipsCompanies named in HIMS's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Hims & Hers Health, Inc. | HIMS | acquirer | Parent company entering into a securities sale deed for an acquisition. | 2026-02-19 | View |
| Hims, Inc. | HIMS | partner | Guarantor for the obligations under the Securities Sale Deed. | 2026-02-19 | View |
| Horizon BidCo Pty Ltd | — | acquirer | Wholly-owned subsidiary of Hims & Hers Health, Inc. acting as the Purchaser in the acquisition. | 2026-02-19 | View |
| EUC Management Pty Ltd | — | target | Target company (d/b/a Eucalyptus) whose equity is being acquired. | 2026-02-19 | View |
| Mendel New Albany Property Owner LLC | — | partner | Landlord for office and manufacturing lease agreement | 2025-09-05 | View |
| Morgan Stanley & Co. LLC | MS-PL | investor | Initial purchaser of convertible notes and counterparty to capped call transactions | 2025-05-13 | View |
| Goldman Sachs & Co. LLC | GSCE | investor | Counterparty to capped call transactions | 2025-05-13 | View |
| BNP Paribas | — | investor | Counterparty to capped call transactions | 2025-05-13 | View |
| Wells Fargo Bank, National Association | — | investor | Counterparty to capped call transactions | 2025-05-13 | View |
| Barclays Bank PLC | TAPR | investor | Counterparty to capped call transactions | 2025-05-13 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-10 | Earnings Release; Exhibits | View | |
| 2026-07-17 | Officer/Director Change | View | |
| 2026-07-01 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-06-15 | Shareholder Vote | View | |
| 2026-06-02 | Material Agreement; Financial Obligation; Other Events; Exhibits | Agreement | View |
| 2026-05-21 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-05-19 | Other Events; Exhibits | View | |
| 2026-03-11 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-02-23 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-19 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-11-17 | Other Events | View | |
| 2025-11-03 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-02 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-09-22 | Other Events | View | |
| 2025-09-05 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-08-04 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-06-17 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-13 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-05-09 | Other Events; Financial Statements and Exhibits | View | |
| 2025-05-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR